MAP3K11 |
MAP3K11, MLK3, PTK1, SPRK: Mitogen-activated protein kinase kinase kinase 11 |
IRS2 |
IRS2: Insulin receptor substrate 2 |
0.265 |
Evidence |
|
MAG |
MAG, GMA: Myelin-associated glycoprotein precursor |
CD80 |
CD80, CD28LG, CD28LG1, LAB7: T-lymphocyte activation antigen CD80 precursor |
0.265 |
Evidence |
|
JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
RIPK1 |
RIPK1, RIP: Receptor-interacting serine/threonine-protein kinase 1 |
0.265 |
Evidence |
|
SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
STK24 |
STK24, MST3, STK3: Serine/threonine-protein kinase 24 |
0.265 |
Evidence |
|
PLEK |
PLEK, P47: Pleckstrin |
PKN2 |
PKN2, PRK2, PRKCL2: Serine/threonine-protein kinase N2 |
0.265 |
Evidence |
|
COL5A2 |
IPI00293881 |
LAMA2 |
LAMA2: Uncharacterized protein LAMA2 |
0.265 |
Evidence |
|
GTF2F1 |
GTF2F1, RAP74: Transcription initiation factor IIF subunit alpha |
BAZ1B |
BAZ1B, WBSC10, WBSCR10, WBSCR9, WSTF: Bromodomain adjacent to zinc finger domain |
0.265 |
Evidence |
|
SERPINA1 |
SERPINA1, AAT, PRO0684, PI, PRO2209: Alpha-1-antitrypsin precursor |
C9 |
C9: Complement component C9 precursor [Contains: Complement component C9a; Compl |
0.265 |
Evidence |
|
ROCK1 |
ROCK1: Rho-associated protein kinase 1 |
NEK7 |
NEK7: Serine/threonine-protein kinase Nek7 |
0.265 |
Evidence |
|
VAV1 |
VAV1, VAV: Proto-oncogene vav |
MAP3K5 |
MAP3K5, ASK1, MAPKKK5, MEKK5: Mitogen-activated protein kinase kinase kinase 5 |
0.265 |
Evidence |
|
PIK3CD |
PIK3CD: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta i |
CRKL |
CRKL: Crk-like protein |
0.265 |
Evidence |
|
VASP |
VASP: Vasodilator-stimulated phosphoprotein |
DYNC1LI1 |
DYNC1LI1, DNCLI1: Cytoplasmic dynein 1 light intermediate chain 1 |
0.265 |
Evidence |
|
F13B |
F13B: Coagulation factor XIII B chain precursor |
C8B |
C8B: Complement component C8 beta chain precursor |
0.265 |
Evidence |
|
CREBBP |
CREBBP, CBP: CREB-binding protein |
FOXJ2 |
FOXJ2, FHX: Forkhead box protein J2 |
0.265 |
Evidence |
|
STK16 |
IPI00480017 |
PLD1 |
PLD1: Phospholipase D1 |
0.265 |
Evidence |
|
SP3 |
SP3: Transcription factor Sp3 |
TRIM28 |
TRIM28, KAP1, RNF96, TIF1B: Transcription intermediary factor 1-beta |
0.265 |
Evidence |
|
CD3G |
CD3G, T3G: T-cell surface glycoprotein CD3 gamma chain precursor |
ITGA4 |
ITGA4, CD49D: Integrin alpha-4 precursor |
0.265 |
Evidence |
|
MAP3K8 |
MAP3K8, COT, ESTF: Mitogen-activated protein kinase kinase kinase 8 |
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
0.265 |
Evidence |
|
CD4 |
CD4: T-cell surface glycoprotein CD4 precursor |
ITGA4 |
ITGA4, CD49D: Integrin alpha-4 precursor |
0.265 |
Evidence |
|
RIPK1 |
RIPK1, RIP: Receptor-interacting serine/threonine-protein kinase 1 |
PSCD4 |
PSCD4, CYT4: Cytohesin-4 |
0.265 |
Evidence |
|
MAP3K14 |
MAP3K14, NIK: Mitogen-activated protein kinase kinase kinase 14 |
DOK1 |
DOK1: Docking protein 1 |
0.265 |
Evidence |
|
SP100 |
IPI00011675 |
TCF8 |
ZEB1, AREB6, TCF8: Zinc finger E-box-binding homeobox 1 |
0.265 |
Evidence |
|
CXorf9 |
IPI00004504 |
SH2D2A |
SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A |
0.265 |
Evidence |
|
PTPN12 |
PTPN12: Tyrosine-protein phosphatase non-receptor type 12 |
ROCK1 |
ROCK1: Rho-associated protein kinase 1 |
0.265 |
Evidence |
|
C7 |
C7: Complement component C7 precursor |
IGFBP4 |
IGFBP4, IBP4: Insulin-like growth factor-binding protein 4 precursor |
0.265 |
Evidence |
|